• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Lets Move Ahead With IP-Watch 2.0: We Need Your Input!

04/10/2019 By Carolyn Deere, Intellectual Property Watch Leave a Comment

What’s new in the international policymaking on intellectual property, innovation and information? What’s at stake at this year’s @WIPO Assemblies? This is first year since […]

Transition At IP-Watch: A New Path Forward

25/03/2019 By Intellectual Property Watch, Intellectual Property Watch 4 Comments

Dear Readers, After 15 years of original, independent, thoughtful, and timely reporting on global policymaking from the inside, Intellectual Property Watch (IP-Watch) is announcing today a pause on reporting services as it embarks on a transition phase to devise new strategies for future work.

Health Policy Watch – Continuing The IP-Watch Tradition Of Vibrant Health Reporting

25/03/2019 By Intellectual Property Watch, Intellectual Property Watch Leave a Comment

Following today’s announcement of a one-year pause on IP-Watch reporting, we invite all IP-Watch readers to sign up here for free daily, weekly or monthly news bulletins from our sister publication, Health Policy Watch, which will include health-related IP reporting as part of its portfolio. You can follow Health Policy Watch (www.healthpolicy-watch.org) on Twitter @HealthPolicyW.

Features

Everything Is Obvious

25/03/2019 By Intellectual Property Watch 4 Comments

Interview With Charles Gore, Medicines Patent Pool Executive Director

22/03/2019 By Intellectual Property Watch 1 Comment

South Africa Moves Forward With Creator Rights Agenda

21/03/2019 By Intellectual Property Watch 5 Comments

Innovation And Regulation Of Gene-Edited Vegetables: An Interview With IP Lawyer Chris Holly

05/03/2019 By Intellectual Property Watch Leave a Comment

Fifa Rahman

Will US Drug Pricing Politics Change Intimidation Practices Globally?

05/03/2019 By Intellectual Property Watch 2 Comments

More features...

Latest News

EU Agrees To Accede To Controversial WIPO Agreement Raising GI Protection

20/03/2019 By William New, Intellectual Property Watch 1 Comment

Inventors, Licensing Groups Back US Withdrawal From Standards-Essential Patent Pact

20/03/2019 By William New, Intellectual Property Watch Leave a Comment

WIPO Election: Who Will Run To Be The Next Director General?

18/03/2019 By William New, Intellectual Property Watch Leave a Comment

Max Planck Institute Director Reto Hilty: Europe Might Miss Chance For Real Copyright Law Modernization

16/03/2019 By Monika Ermert for Intellectual Property Watch 2 Comments

Record Cybersquatting Cases Filed With WIPO In 2018

15/03/2019 By David Branigan, Intellectual Property Watch Leave a Comment

More stories...

Contributors

The Future Of The Ideas Business – The Rise Of Data-Driven Invention

07/12/2018 By Intellectual Property Watch, Intellectual Property Watch 1 Comment

New ideas are getting harder to find, and with less ideas there is a decline in organisational productivity and economic growth. This isn’t new, nor is the fact that to counterbalance the decline in idea generation, research and development have received and continue to require heavy investment. But with daily news of innovation centres opening up across the globe, the question remains whether initiatives like open innovation, crowdsourcing, or simply putting more scientific brains together will do this investment justice.

Last month, leading representatives of the IP, R&D and technology arenas met in Switzerland to discuss a technology-based alternative to human only idea generation. Hosted by data-driven invention company Iprova, the 2nd Data-Driven Invention Forum saw attendees from companies, such as Panasonic, Philips and DuPont as well as many other global organisations explore the future of innovation and the role data-driven invention plays in it. Here are some of the conclusions of the conference.

More contributions...

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting